Contact Information: Media Inquiries Amy Groden-Morrison TIBCO Software Inc. 617-702-1710 amorriso@tibco.com http://spotfire.tibco.com Toni Iafrate Davies Murphy Group 781-418-2406 tiafrate@daviesmurphy.com http://daviesmurphy.com
TIBCO Spotfire Extends Leadership Position in Life Sciences
Analytics Platform of Choice for Leading Pharmaceutical Companies Gains Momentum With Research and Clinical Product Innovation, Pharma-Focused Business Applications
| Source: TIBCO Software Inc.
SOMERVILLE, MA--(Marketwire - October 19, 2009) - TIBCO Software Inc. (NASDAQ : TIBX ) today
announced a strategic push to extend its leadership position in the global
life sciences market with the release of several research and clinical
analysis solutions, including Integromics Biomarker Discovery 2.0 for TIBCO
Spotfire®, TIBCO Spotfire® Lead Discovery 2.0, TIBCO Spotfire®
Pipeline Pilot Connector, and TIBCO Spotfire® Clinical Graphics 2.0.
These solutions deliver integrated informatics and analysis, are central to
research & development efforts in the life sciences industry and can
transform the process of bringing life-saving medicines to market. Access
to actionable knowledge early in the commercialization process of a new
drug can lead to better safety outcomes for patients, and better regulatory
and commercial outcomes for the industry.
The TIBCO
Spotfire® Enterprise Analytics Platform is designed to become an
essential tool for every decision maker in the pharmaceutical/biotech
industry -- from the scientist in the lab to the head of R&D. Timely and
reliable access to essential scientific and operational data will drive
informed decisions leading to better productivity. Data transparency
enabled by the ability to integrate with the majority of current data
sources further enhances the value of these corporate data assets and
improves the quality of key decisions.
"Delivering novel medicines that serve the needs of patients and meet new,
more stringent regulatory and reimbursement pressures is becoming
increasingly difficult. Pharmaceutical and biotech companies are under
increasing pressure to capitalize on all their data assets -- from early
Discovery and late stage Clinical Development to financial, logistical and
operational data -- to better enable the process of bringing new medicines
to market that are safe, efficacious and effective," said Mark Lorion, vice
president of Marketing, TIBCO Spotfire. "Spotfire has an outstanding track
record of providing innovative analytics and visualization capabilities to
the pharmaceutical and biotechnology industry globally and has deep domain
expertise in this space."
Innovating Life Sciences Research Analysis
The introduction of Integromics Biomarker
Discovery 2.0 for TIBCO Spotfire® sets a new standard for advanced
methods for data access, normalization, pattern detection, treatment
comparison, and functional analysis for scientists analyzing genomic
expression data.
TIBCO Spotfire® Lead Discovery 2.0 allows
chemists and biologists to quickly access chemical and biological data in a
single analysis environment, then easily build best-practice applications
for analyzing structure-activity relationships. With unparalleled data
integration, one-step deployment, and summarized views for understanding
new leads in context, the software offers intuitive visualizations and best
practice analytics processes that any discovery team scientist can use to
quickly ask and answer his or her own questions and drive better decisions.
The newly released TIBCO Spotfire® Pipeline Pilot Connector brings the power
of Accelrys' Pipeline Pilot engine to the fingertips of every TIBCO
Spotfire® user. Discovery scientists can now benefit from Pipeline
Pilot's extensive chem- and bio-informatics toolkit to enrich the data
available for interactive visual analysis in TIBCO Spotfire®, leading to
more informed decisions in advancing
discovery-phase projects.
TIBCO Spotfire is hosting a series of upcoming webcasts that profile these
new solutions and feature customers, such as a leading Denmark-based
pharmaceutical company, discussing how real-world scientists and
researchers are gaining an edge with analytics. For complete information
on the series, visit http://goto.spotfire.com/g/?YYM5SS96SH.
Speeding Clinical Trials and Development
The global focus on improving the safety of drugs will drive the need to
identify and address safety issues as early as possible in the drug
discovery and development process. Early attrition of unsuitable drug
candidates can dramatically reduce costs and improve patient outcomes.
With TIBCO Spotfire® Clinical Graphics 2.0, pharmaceutical
organizations are now better equipped to communicate key pre-clinical and
clinical information more effectively across the organization and to
regulatory agencies, making important, real-time business decisions about
their drug development candidates and strategies.
TIBCO Spotfire® Clinical Graphics 2.0 provides a palette of
best-practice, statistical graphics for use in exploratory data analysis,
clinical study reports, submission documents, presentations and journal
articles. Enhanced visualizations -- including tree maps, patient profile
plots, and area bar charts
-- empower translational research by combining genomic, demographic, and
safety data to enable new insights into safety, efficacy, and patient
populations. Graphs can be created using a
point-and-click interface, without the need for programming.
Three of the world's leading global pharmaceutical and biotech companies
are among the Spotfire customers leveraging the TIBCO Spotfire platform to
drive shorter development cycles and faster approvals of drugs that are
safe and effective. Leading clinical data analysis experts from these
companies outlined their methods on a complimentary Webcast that can be
accessed and viewed at:
http://spotfire.tibco.com/ContentCenter/Webcasts/04_22_2009.aspx.
Availability
Integromics Biomarker Discovery 2.0 for TIBCO Spotfire®, TIBCO
Spotfire® Lead Discovery 2.0, TIBCO Spotfire® Pipeline Pilot Connector,
and TIBCO Spotfire® Clinical Graphics 2.0 are available now. For more
information visit: http://goto.spotfire.com/g/?YYM5SS96SH.
About TIBCO
TIBCO Software Inc. (NASDAQ : TIBX ) is a leading provider of enterprise
analytics software for next generation business intelligence. TIBCO
Spotfire products offer a visual and interactive experience that helps
professionals quickly discover new and actionable insights in information.
Distinguished by its speed to insight and adaptability to specific business
challenges, Spotfire rapidly reveals unseen threats and new opportunities,
creating significant economic value. Spotfire customers include industry
leaders among the Global 2000 that have deployed Spotfire analytics to gain
an information advantage over their competitors. For more information,
visit http://spotfire.tibco.com.
TIBCO, TIBCO Software, Spotfire, TIBCO Spotfire Lead Discovery, TIBCO
Spotfire Pipeline Pilot Connector, and TIBCO Spotfire Clinical Graphics are
trademarks or registered trademarks of TIBCO Software Inc. or its
subsidiaries in the United States and/or other countries. Integromics and
Integromics Biomarker Discovery are registered trademarks of Integromics.
All other product and company names and marks mentioned in this document
are the property of their respective owners and are mentioned for
identification purposes only.